612 related articles for article (PubMed ID: 18371543)
1. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
Boyer O; Noël LH; Balzamo E; Guest G; Biebuyck N; Charbit M; Salomon R; Frémeaux-Bacchi V; Niaudet P
Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
[TBL] [Abstract][Full Text] [Related]
2. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
3. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
Boyer O; Balzamo E; Charbit M; Biebuyck-Gougé N; Salomon R; Dragon-Durey MA; Frémeaux-Bacchi V; Niaudet P
Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
[TBL] [Abstract][Full Text] [Related]
4. Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation.
Schejbel L; Schmidt IM; Kirchhoff M; Andersen CB; Marquart HV; Zipfel P; Garred P
Genes Immun; 2011 Mar; 12(2):90-9. PubMed ID: 21270828
[TBL] [Abstract][Full Text] [Related]
5. Mouse podocyte complement factor H: the functional analog to human complement receptor 1.
Alexander JJ; Wang Y; Chang A; Jacob A; Minto AW; Karmegam M; Haas M; Quigg RJ
J Am Soc Nephrol; 2007 Apr; 18(4):1157-66. PubMed ID: 17344423
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic uremic syndrome recurrence after renal transplantation.
Loirat C; Fremeaux-Bacchi V
Pediatr Transplant; 2008 Sep; 12(6):619-29. PubMed ID: 18482212
[TBL] [Abstract][Full Text] [Related]
7. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
Hirt-Minkowski P; Schaub S; Mayr M; Schifferli JA; Dickenmann M; Frémeaux-Bacchi V; Steiger J
Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317
[TBL] [Abstract][Full Text] [Related]
8. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.
Servais A; Noël LH; Dragon-Durey MA; Gübler MC; Rémy P; Buob D; Cordonnier C; Makdassi R; Jaber W; Boulanger E; Lesavre P; Frémeaux-Bacchi V
Hum Pathol; 2011 Sep; 42(9):1305-11. PubMed ID: 21396679
[TBL] [Abstract][Full Text] [Related]
10. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
[TBL] [Abstract][Full Text] [Related]
12. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.
Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M
Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909
[TBL] [Abstract][Full Text] [Related]
13. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
Hirt-Minkowski P; Dickenmann M; Schifferli JA
Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
[TBL] [Abstract][Full Text] [Related]
14. Acute poststreptococcal glomerulonephritis associated with thrombotic microangiopathy in an adult.
Duvic C; Desramé J; Hérody M; Nédélec G
Clin Nephrol; 2000 Aug; 54(2):169-73. PubMed ID: 10968697
[TBL] [Abstract][Full Text] [Related]
15. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
Sethi S; Fervenza FC
Semin Thromb Hemost; 2014 Jun; 40(4):416-21. PubMed ID: 24799306
[TBL] [Abstract][Full Text] [Related]
16. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
[TBL] [Abstract][Full Text] [Related]
17. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
[TBL] [Abstract][Full Text] [Related]
18. C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab.
Garg N; Zhang Y; Nicholson-Weller A; Khankin EV; Borsa NG; Meyer NC; McDermott S; Stillman IE; Rennke HG; Smith RJ; Pavlakis M
Nephrol Dial Transplant; 2018 Dec; 33(12):2260-2265. PubMed ID: 29370420
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic uremic syndrome with hypocomplementemia, serum C3NeF, and glomerular deposits of C3.
Barré P; Kaplan BS; de Chadarévian JP; Drummond KN
Arch Pathol Lab Med; 1977 Jul; 101(7):357-61. PubMed ID: 577389
[TBL] [Abstract][Full Text] [Related]
20. C3 glomerulonephritis associated with a missense mutation in the factor H gene.
Sugimoto K; Fujita S; Miyazaki K; Okada M; Takemura T
Tohoku J Exp Med; 2012 Jul; 227(3):211-5. PubMed ID: 22790979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]